Ultragenyx (RARE) insider buying

Healthcare · Biotechnology · Market cap $1.4B

8 open-market purchases of RARE by Ultragenyx's executives and directors since July 2025, worth $0 in total, from SEC Form 4 filings.

The most recent: Gilbert Ray Cisneros, Jr. bought — on March 3, 2026.

The biggest buyer over the period is Gilbert Ray Cisneros, Jr.: 8 purchases, $0.

By year

YearPurchasesValue
20264$0
20254$0

Biggest buyers

InsiderBuysValue
Gilbert Ray Cisneros, Jr.
8$0

Every purchase

Newest first. From SEC Form 4 filings. Insider buying across the market.

DateInsiderSharesPriceValueFiling
Mar 3, 2026 Gilbert Ray Cisneros, Jr.
0$22.07— —
Mar 3, 2026 Gilbert Ray Cisneros, Jr.
0$22.07— —
Feb 18, 2026 Gilbert Ray Cisneros, Jr.
0$20.45— —
Feb 18, 2026 Gilbert Ray Cisneros, Jr.
0$20.45— —
Aug 8, 2025 Gilbert Ray Cisneros, Jr.
0$27.54— —
Aug 8, 2025 Gilbert Ray Cisneros, Jr.
0$27.54— —
Jul 15, 2025 Gilbert Ray Cisneros, Jr.
0$27.20— —
Jul 15, 2025 Gilbert Ray Cisneros, Jr.
0$27.20— —
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for RARE.
Open RARE in Investingly

Questions

Are Ultragenyx insiders buying the stock?

8 open-market purchases of RARE by Ultragenyx's executives and directors since July 2025, worth $0 in total, from SEC Form 4 filings. The most recent: Gilbert Ray Cisneros, Jr. bought — on March 3, 2026.

What counts as insider buying here?

Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.

From Ultragenyx's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.